New Study Shows Vaporizing Cannabis Significantly Reduces Harmful Byproducts
Vaporizing cannabis harm reduction offers a safer alternative to traditional smoking by significantly reducing harmful combustion byproducts. This method preserves therapeutic compounds while minimizing respiratory irritants. Patients and clinicians…
Medical Cannabis Commission Approves Cultivators, Manufacturing Standards Unclear
The 2026 cannabis manufacturing standards remain unclear despite approval of cultivators by the Medical Cannabis Commission. This regulatory gap impacts product quality and patient safety. Clinicians must navigate these challenges carefully to ensure…
GLP-1 Receptor Agonist Clinical Evidence: Real vs. Risk
Peptide therapeutics safety risks are critical in GLP-1 receptor agonist clinical evidence. Understanding these risks helps clinicians guide patients safely. This article highlights key safety considerations for peptide therapies.
Kentucky Cannabis Association Hosts Medical Marijuana Card Drives – Henderson Today
The Kentucky Cannabis Association is organizing medical marijuana card drives to enhance patient access to cannabis treatments. These drives play a key role in the Kentucky medical cannabis program by facilitating enrollment. The focus on kentucky…
Does Cannabis Legalization Actually Lead to Better Health? – The Afternoon Story
The cannabis legalization push is reshaping public health landscapes with mixed outcomes. Evidence shows both benefits like reduced opioid use and challenges such as increased emergency visits. Clinicians must navigate these changes with informed…
Christian County’s First Medical Cannabis Dispensary Opens in Oak Grove
Kentucky medical cannabis program expands with the opening of Christian County's first dispensary in Oak Grove. This new facility improves patient access and supports safer, regulated treatment. Local access reduces travel burdens and enhances medication…
Understanding the Risks of Counterfeit Semaglutide and Fake Ozempic Pills
Semaglutide counterfeit risks are rising with the proliferation of fake Ozempic pills in unregulated markets. These products pose significant safety concerns due to lack of FDA oversight. Clinicians must be vigilant in screening patients sourcing…
Challenges in Cannabis Testing as Virginia Retail Market Approaches
2026 cannabis testing challenges persist as Virginia's retail market nears launch. Current THC detection methods remain unreliable for assessing impairment. Clinicians must understand these limitations to ensure patient safety.
Medical Cannabis: Is the Pharmacy Sector Ready to Roll? – Chemist+Druggist
Pharmacy integration medical cannabis is a critical shift impacting patient access and safety. The pharmacy sector faces challenges including regulatory complexity and product standardization. Read about the readiness of pharmacies to dispense medical…
Cannabis Testing Challenges Persist as Virginia Retail Market Nears
Laboratory testing inconsistencies cannabis create challenges for patient safety and dosing accuracy in medical cannabis programs. Virginia's retail market faces these issues as testing variability affects product reliability. Patients and clinicians…